The MattCorc Podcast
Life Sciences Rush Hour - Inve
Add to My Podcasts
Episodes
About
Reviews
Promote
S&P Companies not as negative; Gene Therapy manufacturing is stretched thin
7 minutes
Posted Nov 5, 2018 at 6:28 pm.
0:00
7:21
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Happy national doughnut day! Fewer companies in the S&P are providing negative guidance. What does this mean? How CFOs are protecting their balance sheets in the event their manufacturing is disrupted.
Previous
Lessons from Halloween when your kids have peanut allergies
Next
Why cost should only be one consideration
← See all 47 episodes of The MattCorc Podcast